glp 1 receptor agonist moa GLP-1 agonists (GLP-1RAs): cardiovascular actions and therapeutic potential Glucagon-like peptide-1 - Wikipedia

Description

If constipation becomes a problem despite preparation, options worth discussing with your clinician include: A gentle osmotic laxative such as polyethylene glycol (MiraLAX) used on a scheduled rather than as-needed basis during dose escalation periods

The dual mechanism of tirzepatide has a synergistic impact that is strong enough to significantly lower the risk of cardiovascular events [3, 4]

Li concluded, stating that their results indicate a potential lithoprotective benefit from GLP-1A use in obese, at-risk populations

Mechanisms underlying cardiovascular effects of incretin therapy In addition to glycemic effects, GLP-1RAs also favorably modulate multiple cardiovascular risk factors via acting on a variety of organ systems